Full Coverage
Johnson & Johnson single-shot vaccine 85% effective against severe COVID-19 disease
By Sony Salzman
Top news
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim ...
Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says
By Michael Nedelman, Amanda Sealy & Maggie Fox
Johnson & Johnson Vaccine Is 66% Effective In Preventing Moderate To Severe COVID-19
By Scott Hensley
Posts on X
Formerly Twitter
Tedros Adhanom Ghebreyesus
DrTedros
Vaccines are among the most powerful inventions in history, making once-feared diseases preventable.
With continued research, investment and collaboration, we can save millions more lives today and in the next 50 years. #HumanlyPossible
#WorldImmunizationWeek pic.twitter.com/HqBG6ABYuf
Posted on X
Eric Topol
EricTopol
“A month of doses can be manufactured for less than $5, which means that American customers are paying a 200-fold markup or more, with many of them paying it out of pocket.” @dwallacewells @nytopinion www.nytimes.com/2024/04/24/opinion/ozempic-wegovy-weight-glp1.html
Posted on X
NCDC
NCDCgov
Unvaccinated and partially vaccinated individuals are more susceptible to getting infected with diseases such as #COVID19, #diphtheria, #measles, #Meningitis etc.
Visit a primary healthcare facility to get vaccinated if you're unsure of your vaccination status.
#HumanlyPossible… pic.twitter.com/cqqETGsNPs
Posted on X
NCDC
NCDCgov
The #COVID19 pandemic caused a global and national decline in immunisation coverage.
While more than 4 million more children were vaccinated globally in 2022 compared to 2021, there were still 20 million children who missed out on one or more of their vaccines.… pic.twitter.com/V7gZYr7XNz
Posted on X